======= CLPB =======
== Gene Information ==
* **Official Symbol**: CLPB
* **Official Name**: caseinolytic mitochondrial matrix peptidase chaperone subunit B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81570|81570]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H078|Q9H078]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CLPB&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CLPB|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616254|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene belongs to the ATP-ases associated with diverse cellular activities (AAA+) superfamily. Members of this superfamily form ring-shaped homo-hexamers and have highly conserved ATPase domains that are involved in various processes including DNA replication, protein degradation and reactivation of misfolded proteins. All members of this family hydrolyze ATP through their AAA+ domains and use the energy generated through ATP hydrolysis to exert mechanical force on their substrates. In addition to an AAA+ domain, the protein encoded by this gene contains a C-terminal D2 domain, which is characteristic of the AAA+ subfamily of Caseinolytic peptidases to which this protein belongs. It cooperates with Hsp70 in the disaggregation of protein aggregates. Allelic variants of this gene are associated with 3-methylglutaconic aciduria, which causes cataracts and neutropenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015].
* **UniProt Summary**: May function as a regulatory ATPase and be related to secretion/protein trafficking process.
|AAA 5|
|ClpB D2-small|
|AAA|
|Ank|
|Ank 2|
|AAA 2|
|Zeta toxin|
|cellular response to heat|
|response to heat|
|response to temperature stimulus|
|ATPase activity|
|cellular component|
|molecular function|
|response to abiotic stimulus|
|mitochondrion|
|ATP binding|
|cellular response to stress|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp359|FK-506 30μM R07 exp359]]|-1.83|
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.72|
|[[:results:exp59|UMK57 1μM R01 exp59]]|1.73|
|[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.75|
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|1.81|
|[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|1.9|
|[[:results:exp512|Olaparib 4μM R08 exp512]]|1.93|
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.94|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|2.06|
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|2.06|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|2.18|
^Gene^Correlation^
|[[:human genes:y:yme1l1|YME1L1]]|0.417|
|[[:human genes:p:parl|PARL]]|0.416|
|[[:human genes:c:c4orf29|C4orf29]]|0.413|
Global Fraction of Cell Lines Where Essential: 9/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|1/28|
|blood|0/28|
|bone|1/26|
|breast|2/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|1/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|1/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2708
* **Expression level (log2 read counts)**: 5.58
{{:chemogenomics:nalm6 dist.png?nolink |}}